In vivo, anti-inflammatory strategies using for example TNFα-antibodies (51) or reducing the amount of TNF-α in the CSF via inhibition of the TNF-α-converting enzyme (TACE) with doxycycline (52), improved hearing function and reduced cochlear injury in the context of meningitis (51). This evidence concerns the gene TNF and infectious meningitis.